Trial Details

TERMINATED
Basic Information
Clinical ID c1472
Identifier NCT03844932
Trial Title A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Colitis, Ulcerative
Interventions DRUG: ST-0529
Participant Information
Sponsor Sublimity Therapeutics Holdco Limited
City Palm Springs
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2019-01-24
Primary Completion Date 2021-04-14
Completion Date 2021-04-14